Navelbine and Platinol Helpful for Treating Mesothelioma
Jul, 2008 - Patients diagnosed with pleural mesothelioma could benefit from a combination of Navelbine and Platinol, according to Danish researchers. Pleural mesothelioma is a fatal form of cancer caused by asbestos exposure that strikes thousands of U.S. residents annually.
The average survival time for victims of pleural mesothelioma, usually diagnosed late, is less than one year. Studies of the disease indicate that chemotherapy could improve quality of life and prolong a patient’s survival. One of the studies assessed a chemotherapy regimen of Navelbine and Platinol for the treatment of 54 patients with mesothelioma. The 1-year survival rate for these patients was 61%, the 2-year survival rate was 31%, and the 3-year survival rate was 4%. The study reports that these rates were better to previous studies with Gemzar-based chemotherapy combinations.
If you or a loved one have recently been diagnosed with mesothelioma, and are concerned about your legal rights, medical bills or the future welfare of your family, please fill out form on this page for a free legal review of your potential case.
Other helpful links:
Asbestos and lung cancer Asbestos and lung cancer
Mesothelioma attorney Mesothelioma attorney
Mesothelioma Lawyer Mesothelioma lawyer
Asbestos attorney Asbestos attorney